Geron Corp (GERN)
$1.65
0.05 (2.65%)
18:47 EST
GERN Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
285.58M
PE Ratio
-9.71
EPS
-0.17
Volume (Avg. Vol.)
1.87M
Day's Range
1.64 - 1.74
52-Week Range
0.75 - 2.40
Dividend & Yield
N/A (N/A)
GERN Stock Predictions, Articles, and Geron Corp News
- From InvestorPlace
- From the Web
7 Penny Stocks To Buy with Massive Upside Potential
There could be a reason penny stocks trade for under $5, but the returns can be monstrous if there's even minor share price appreciation.
7 Healthcare Stocks With 100% Street Support
When searching for massive gains that can be achieved in the blink of an eye, look no further than healthcare stocks. Here are seven that stand out according to the Street.
5 Top Stock Trades for Friday — BBBY, RAD and NFLX
Geron plunged almost 70% and Bed Bath & Beyond dropped more than 20%. Here are our top stock trades for Friday.
7 Biotech Stocks to Buy Now
Biotech companies are recovering nicely this year. With a quarter left to go, the upside potential is high for those biotech stocks that dipped recently.
Geron Corporation Stock Shoots Up on Job Posting News
Geron Corporation (GERN) stock went gangbusters on Friday as partner Johnson & Johnson (JNJ) opened a new job position for an EMEA Strategic Pricing Manager.
8 Undervalued Biotech Stocks to Watch
Volatility across all categories of biotech stocks makes this present juncture an ideal time to consider picking up undervalued names.
5 Risky, But Rewarding, Ways to Play the Rebound
These stocks and ETFs to buy have a good chance to give investors handsome rewards; however, they are not without significant risk.
24 Biotechnology Stocks to Sell Now
This week, the ratings of 24 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Gilead Sciences, Inc. (GILD) Stock Falters on Q3 Earnings Miss
Gilead Sciences (GILD) struggled in its third quarter thanks to lower Hepatitis C treatment sales. GILD stock is being punished as a result.
23 Biotechnology Stocks to Sell Now
This week, the overall grades of 23 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Battered Biotechs That Could Turn Things Around
Biotechs like NVAX, GERN and RGLS have made a name for themselves for all the wrong reasons, but they also have a chance at redemption.
Biggest Movers in Manufacturing Stocks Now – GALT CERC OVAS EBIO
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Why Geron Corporation (GERN), Polaris Industries Inc. (PII) and VimpelCom Ltd (ADR) (VIP) Are 3 of Today’s Worst Stocks
Polaris (PII), VimpelCom (VIP) and Geron (GERN) were conspicuously left out of Monday's rebound rally. Here's what you need to know.
Biggest Movers in Manufacturing Stocks Now – RPTP CSTE SORL WATT
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
19 Biotechnology Stocks to Sell Now
This week, the ratings of 19 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
20 Cheap Stocks Under $10 Worth Zilch
By
Jeff Reeves
Cheap stocks under $10 are tempting because of their low share price, but some picks are cheap for a reason. Avoid these "bargain" stocks!

Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
Buy